Celltrion Healthcare Co Equity 2024

Celltrion Healthcare Co Aktienanalyse

What does Celltrion Healthcare Co do?

Celltrion Healthcare Co Ltd is a leading South Korean biopharmaceutical company that focuses on the development and manufacturing of biological drugs for the treatment of severe and complex diseases. The company was founded in 2009 and is headquartered in Incheon, South Korea. Celltrion Healthcare Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Celltrion Healthcare Co's Equity

Celltrion Healthcare Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Celltrion Healthcare Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Celltrion Healthcare Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Celltrion Healthcare Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Celltrion Healthcare Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Celltrion Healthcare Co stock

What is the equity of Celltrion Healthcare Co this year?

Celltrion Healthcare Co has equity of 2.06 T KRW this year.

What was the equity of Celltrion Healthcare Co compared to the previous year?

The equity of Celltrion Healthcare Co has increased/decreased by -2.09% decreased compared to the previous year.

What impact does a high equity have on investors of Celltrion Healthcare Co?

A high equity is advantageous for investors of Celltrion Healthcare Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Celltrion Healthcare Co?

A low equity can be a risk for investors of Celltrion Healthcare Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Celltrion Healthcare Co affect the company?

An increase in equity of Celltrion Healthcare Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Celltrion Healthcare Co affect the company?

A reduction in equity of Celltrion Healthcare Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Celltrion Healthcare Co?

Some factors that can affect the equity of Celltrion Healthcare Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Celltrion Healthcare Co so important for investors?

The equity of Celltrion Healthcare Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Celltrion Healthcare Co take to change the equity?

To change equity, Celltrion Healthcare Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Celltrion Healthcare Co pay?

Over the past 12 months, Celltrion Healthcare Co paid a dividend of 125 KRW . This corresponds to a dividend yield of about 0.16 %. For the coming 12 months, Celltrion Healthcare Co is expected to pay a dividend of 132.37 KRW.

What is the dividend yield of Celltrion Healthcare Co?

The current dividend yield of Celltrion Healthcare Co is 0.16 %.

When does Celltrion Healthcare Co pay dividends?

Celltrion Healthcare Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Celltrion Healthcare Co?

Celltrion Healthcare Co paid dividends every year for the past 6 years.

What is the dividend of Celltrion Healthcare Co?

For the upcoming 12 months, dividends amounting to 132.37 KRW are expected. This corresponds to a dividend yield of 0.17 %.

In which sector is Celltrion Healthcare Co located?

Celltrion Healthcare Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Celltrion Healthcare Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Celltrion Healthcare Co from 3/1/2023 amounting to 125 KRW, you needed to have the stock in your portfolio before the ex-date on 12/28/2022.

When did Celltrion Healthcare Co pay the last dividend?

The last dividend was paid out on 3/1/2023.

What was the dividend of Celltrion Healthcare Co in the year 2023?

In the year 2023, Celltrion Healthcare Co distributed 125 KRW as dividends.

In which currency does Celltrion Healthcare Co pay out the dividend?

The dividends of Celltrion Healthcare Co are distributed in KRW.